Le Lézard
Classified in: Health
Subjects: MAV, FVT, CFG

Media Advisory - Minister Petitpas Taylor to Discuss Pharmacare and Budget 2019 in Amherst, Nova Scotia

OTTAWA, March 22, 2019 /CNW/ - The Honorable Minister of Health, Ginette Petitpas Taylor will visit Maggie's Place: A Resource Centre for Families in Amherst, Nova Scotia where she will tour the Centre and meet with volunteers.

A media availability will follow where Minister Petitpas Taylor will highlight Pharmacare and Budget 2019.

Monday, March 25, 2019

11 Elmwood Drive
Amherst, NS B4H 4L2

Times (all times local)
Minister Petitpas Taylor's tour of Maggie's Place: A Resource Centre for Families ? 2:00 p.m. ADT
Minister Petitpas Taylor's media availability ? 3:00 p.m. ADT


SOURCE Health Canada

These press releases may also interest you

at 04:10
According to a new joint study conducted by scientists at Global Lyme Alliance (GLA) and Brown University, more than two million people in the United States could suffer profound disability from post treatment Lyme disease syndrome (PTLD) by the year...

at 04:00
Emendo Biotherapeutics Inc today announced that the company signed a licensing option agreement with Takeda Pharmaceutical Company Limited. As part of the transaction, Emendo will receive an investment in convertible notes from Takeda Ventures, Inc.,...

at 04:00
Researchers of the Erasmus University Medical Center in Rotterdam ? the Netherlands, consider that the synthetic and fully resorbable TIGR® Matrix surgical mesh (Novus Scientific AB, Uppsala ? Sweden) may reduce frequent risks related to the surgical...

at 03:45
The new Michigan Paid Medical Leave Act (PMLA) took place back on March 29, 2019 that requires employers in the state of Michigan with 50 employees or more to supply their employees with paid medical leave. Employers have the option to give employees...

at 03:35
Rexgenero, a regenerative medicine company pioneering the development of advanced cell-based therapies to treat critical limb ischaemia (CLI), today presented an update on its two Phase III SALAMANDER trials being conducted...

at 03:05
Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) product platform, announced today that Punit Upadhyaya, Ph.D., Senior Scientist at...

News published on 22 march 2019 at 19:05 and distributed by: